BEAM: A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma

Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf, Gerald P. Linette, Svetomir N. Markovic, David F. McDermott, Jeffrey S. Weber, Hoa Nguyen, Peter Cheverton, Daniel Chen, Amy C. Peterson, William E. Carson, Steven J. O'Day

Research output: Contribution to journal › Article › peer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'BEAM: A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences